Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts
This handbook for businesses on pandemic response lessons learned with some considerations businesses can look at on re-opening, vaccine hesitancy, preparing for the next pandemic now, etc. was developed by the Northeast Business Group on Health. Continue reading
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization. This includes those who are 65 years of age or older, or who have certain chronic medical conditions.Continue reading
COVID-19 Vaccines are viewed as the light at the end of the tunnel. We are not there yet but we will get there. Hundreds of millions of people in the United States and billions of people globally will need to be immunized against COVID-19. But, are these vaccines safe and effective? Would you recommend that someone you love get one?
On February 2, 2021, AZBio and a coalition of health and community organizations hosted an in depth discussion on how vaccines impact Arizona’s Economy. The encore video is now available.Continue reading
TUCSON, Ariz. — Researchers at the University of Arizona are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes.Continue reading
An investigational COVID-19 vaccine developed by Janssen Pharmaceuticals appears to be safe and effective at preventing moderate and severe COVID-19 in adults, according to an interim analysis of Phase 3 clinical data conducted Jan. 21. The vaccine, called Ad.26.COV2.S or JNJ-78436725, requires only a single injection and can be stored in a refrigerator for months.Continue reading